EMA’s Annual Report on the EudraVigilance Database

Europe On 27 March 2019, the Annual Report 2018 on the European database for the collection of adverse reactions to medicinal products, Eudravigilance, was published by the EMA. It’s a summary of the current status of the database. EudraVigilance is used to...

New and improved version of Eudravigilance

EMA On 22 November 2017, a new and improved version of EudraVigilance will be launched by the European Medicines Agency (EMA). Users of this system, including marketing authorization holders and sponsors of clinical trials, should prepare themselves to ensure that...